Skip to content

Clinical trials

Terminated Endometrial Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Endometrial Neoplasms Status: Terminated Country / region: United States Clear all

86 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20042
20062
20071
20082
20093
20102
20111
20121
20131
20142
20155
20162
20175
20184
20195
20206
202115
202211
20235
20245
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated86

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gynecologic Oncology Group4
M.D. Anderson Cancer Center4
Pfizer4
Alaunos Therapeutics2
Genmab2
Incyte Corporation2
Lyell Immunopharma, Inc.2
Mayo Clinic2
Novartis Pharmaceuticals2
Seagen Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Endometrial Neoplasms86
Ovarian Neoplasms36
Uterine Cervical Neoplasms20
Breast Neoplasms19
Stomach Neoplasms17
Carcinoma, Non-Small-Cell Lung16
Neoplasm Metastasis14
Lung Neoplasms12
Triple Negative Breast Neoplasms11
Colonic Neoplasms10

Trials

Showing 1 to 25 of 86. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.